Foghorn Therapeutics Inc. FHTX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

60/100

4/7 Pass

SharesGrow Intrinsic Value

Foghorn Therapeutics Inc. (FHTX) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Flagship Pioneering Inc. con 1,814,914 acciones. Otros tenedores destacados incluyen Flagship Pioneering, LLC y GOTTSCHALK ADRIAN.

En los últimos 12 meses, los internos han realizado 22 transacciones en FHTX acciones — 18 compras (valoradas en $39.04M) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.

FHTX Participación de Insiders

Principal Titular

Flagship Pioneering Inc.

1,814,914 acciones

Compras (12 meses)

$39.04M valor

Ventas (12 meses)

$0.00 valor

Actividad de Transacciones (12 meses)

Comprar 82%

Vender 0%

Principales Titulares Internos

#	Nombre	Cargo	Acciones en Propiedad	Última Declaración	Tamaño Relativo
1	Flagship Pioneering Inc.	10 Percent Owner	1,814,914	2024-05-24	100%
2	Flagship Pioneering, Llc	10 Percent Owner	1,117,734	2026-01-15	62%
3	Gottschalk Adrian	Chief Executive Officer	1,075,000	2026-02-06	59%
4	Maynard Ryan D	Chief Financial Officer	400,000	2026-02-24	22%
5	Bellon Steven F.	Chief Scientific Officer	300,000	2026-02-02	17%
6	Cardama Alfonso Quintas	Chief Medical Officer	300,000	2026-02-02	17%
7	Lacascia Michael	Chief Legal Officer	295,000	2026-02-02	16%
8	Costa Carlos	Chief People Officer	230,000	2026-02-02	13%
9	Rivkin Anna	Chief Business Officer	165,000	2026-02-02	9%
10	Humer Kristian	Chief Financial Officer	120,000	2025-01-24	7%
11	Baselga Jose	Director	94,594	2020-10-22	5%
12	Reine Allan	Chief Financial Officer	90,000	2023-01-30	5%
13	Cavalie Fanny	Chief Strategy/bus Ops Officer	75,992	2024-03-12	4%
14	Agresta Samuel	Chief Medical Officer	60,000	2023-01-30	3%
15	Gallagher Neil	Director	50,000	2025-05-02	3%
16	Duty Stuart	Director	50,000	2025-05-02	3%
17	Decicco Carl	Chief Scientific Officer	34,273	2021-12-13	2%
18	Cole Douglas G.	Director	25,000	2025-06-17	1%
19	Parshall B Lynne	Director	25,000	2025-06-17	1%
20	Biller Scott	Director	25,000	2025-06-17	1%

Transacciones Recientes (últimos 12 meses)

Fecha	Nombre	Cargo	Tipo	Acciones	Precio	Valor
2026-02-23	Maynard Ryan D	Chief Financial Officer	Concesión de RSU	400,000	$5.75	$2.3M
2026-02-23	Maynard Ryan D	Officer	Desconocido	-	-	-
2026-02-05	Gottschalk Adrian	Chief Executive Officer	Concesión de RSU	1,075,000	$5.23	$5.62M
2026-01-30	Rivkin Anna	Chief Business Officer	Concesión de RSU	165,000	$5.71	$942.15K
2026-01-30	Costa Carlos	Chief People Officer	Concesión de RSU	230,000	$5.71	$1.31M
2026-01-30	Lacascia Michael	Chief Legal Officer	Concesión de RSU	295,000	$5.71	$1.68M
2026-01-30	Bellon Steven F.	Chief Scientific Officer	Concesión de RSU	300,000	$5.71	$1.71M
2026-01-30	Cardama Alfonso Quintas	Chief Medical Officer	Concesión de RSU	300,000	$5.71	$1.71M
2026-01-13	Flagship Pioneering, Llc	10 Percent Owner	Concesión de RSU	1,117,734	$20.13	$22.5M
2025-11-14	Humer Kristian	Officer	Desconocido	-	-	-
2025-06-17	Mendelsohn Michael	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Biller Scott	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Cole Douglas G.	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Lynch Thomas J. Jr.	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Smith Ian F	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Gill Simba	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-06-17	Parshall B Lynne	Director	Concesión de RSU	25,000	$4.79	$119.75K
2025-05-01	Gallagher Neil	Director	Concesión de RSU	50,000	$4.16	$208K
2025-05-01	Gallagher Neil	Officer	Desconocido	-	-	-
2025-05-01	Duty Stuart	Director	Concesión de RSU	50,000	$4.16	$208K
2025-05-01	Duty Stuart	Officer	Desconocido	-	-	-
2025-04-25	Gottschalk Adrian	Chief Executive Officer	Donación (Recibida)	300,000	-	-